DE69831413D1 - Il-8 rezeptor antagonisten - Google Patents
Il-8 rezeptor antagonistenInfo
- Publication number
- DE69831413D1 DE69831413D1 DE69831413T DE69831413T DE69831413D1 DE 69831413 D1 DE69831413 D1 DE 69831413D1 DE 69831413 T DE69831413 T DE 69831413T DE 69831413 T DE69831413 T DE 69831413T DE 69831413 D1 DE69831413 D1 DE 69831413D1
- Authority
- DE
- Germany
- Prior art keywords
- receptor antagonists
- antagonists
- receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 108090001007 Interleukin-8 Proteins 0.000 title 1
- 239000002464 receptor antagonist Substances 0.000 title 1
- 229940044551 receptor antagonist Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
- C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Physical Education & Sports Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Toxicology (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Dermatology (AREA)
- Vascular Medicine (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5799797P | 1997-09-05 | 1997-09-05 | |
| PCT/US1998/018563 WO1999011253A1 (en) | 1997-09-05 | 1998-09-04 | Il-8 receptor antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69831413D1 true DE69831413D1 (de) | 2005-10-06 |
| DE69831413T2 DE69831413T2 (de) | 2006-06-14 |
Family
ID=22014018
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69831413T Expired - Fee Related DE69831413T2 (de) | 1997-09-05 | 1998-09-04 | Il-8 rezeptor antagonisten |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US6316478B1 (de) |
| EP (1) | EP1003497B1 (de) |
| JP (1) | JP2001514217A (de) |
| KR (1) | KR20010023673A (de) |
| CN (1) | CN1278721A (de) |
| AR (1) | AR015426A1 (de) |
| AT (1) | ATE303370T1 (de) |
| AU (1) | AU731182B2 (de) |
| BR (1) | BR9811751A (de) |
| CA (1) | CA2302364A1 (de) |
| CO (1) | CO4970746A1 (de) |
| DE (1) | DE69831413T2 (de) |
| ES (1) | ES2248916T3 (de) |
| HK (1) | HK1028730A1 (de) |
| HU (1) | HUP0003581A3 (de) |
| IL (1) | IL134854A0 (de) |
| NO (1) | NO315467B1 (de) |
| NZ (1) | NZ503125A (de) |
| PL (1) | PL339133A1 (de) |
| TR (1) | TR200000610T2 (de) |
| WO (1) | WO1999011253A1 (de) |
| ZA (1) | ZA988101B (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR008331A1 (es) * | 1997-01-23 | 1999-12-29 | Smithkline Beecham Corp | Compuestos antagonistas de un receptor de il-8, uso de los mismos para la fabricacion de medicamentos, procedimiento para su obtencion, composicionesfarmaceuticas que los contienen |
| US6664259B2 (en) * | 2000-03-16 | 2003-12-16 | Smithkline Beecham Corporation | Il-8 receptor antagonists |
| DE10038709A1 (de) * | 2000-08-09 | 2002-02-28 | Aventis Pharma Gmbh | Substituierte und unsubstituierte Benzooxathiazole sowie daraus abgeleitete Verbindungen |
| AR041834A1 (es) * | 2002-10-29 | 2005-06-01 | Smithkline Beecham Corp | Compuesto de difenilurea sustituido con sulfonamida, composicion farmaceutica que lo comprende y su uso para preparar dicha composicion |
| JP2007537272A (ja) | 2004-05-12 | 2007-12-20 | シェーリング コーポレイション | Ｃｘｃｒ１およびｃｘｃｒ２ケモカインアンタゴニスト |
| US20070249625A1 (en) * | 2004-10-20 | 2007-10-25 | Jakob Busch-Petersen | Il-8 Receptor Antagonists |
| KR101376472B1 (ko) * | 2006-04-21 | 2014-03-19 | 글락소스미스클라인 엘엘씨 | Ｉｌ８ 수용체 길항제 |
| WO2007124423A2 (en) * | 2006-04-21 | 2007-11-01 | Smithkline Beecham Corporation | Il-8 receptor antagonists |
| TW200817006A (en) * | 2006-06-23 | 2008-04-16 | Smithkline Beecham Corp | IL-8 receptor antagonist |
| KR101182114B1 (ko) * | 2010-03-05 | 2012-09-12 | 한림제약(주) | 유효성분으로서 레바미피드를 함유하는 골관절염 예방 또는 치료용 약학 조성물 |
| AU2017291886B2 (en) | 2016-07-04 | 2021-11-25 | Bayer Cropscience Aktiengesellschaft | Benzosultams and analogues and their use as fungicides |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1327482A (en) * | 1970-06-30 | 1973-08-22 | Leo Pharm Prod Ltd | 1,2-benzisothiazole-1,1-dioxide derivatives |
| US5593993A (en) * | 1991-08-02 | 1997-01-14 | Medivir Ab | Method for inhibition of HIV related viruses |
| AR008331A1 (es) * | 1997-01-23 | 1999-12-29 | Smithkline Beecham Corp | Compuestos antagonistas de un receptor de il-8, uso de los mismos para la fabricacion de medicamentos, procedimiento para su obtencion, composicionesfarmaceuticas que los contienen |
-
1998
- 1998-09-01 AR ARP980104363A patent/AR015426A1/es unknown
- 1998-09-04 US US09/486,986 patent/US6316478B1/en not_active Expired - Fee Related
- 1998-09-04 DE DE69831413T patent/DE69831413T2/de not_active Expired - Fee Related
- 1998-09-04 AT AT98944775T patent/ATE303370T1/de not_active IP Right Cessation
- 1998-09-04 JP JP2000508356A patent/JP2001514217A/ja active Pending
- 1998-09-04 ZA ZA988101A patent/ZA988101B/xx unknown
- 1998-09-04 HU HU0003581A patent/HUP0003581A3/hu unknown
- 1998-09-04 WO PCT/US1998/018563 patent/WO1999011253A1/en active IP Right Grant
- 1998-09-04 EP EP98944775A patent/EP1003497B1/de not_active Expired - Lifetime
- 1998-09-04 IL IL13485498A patent/IL134854A0/xx unknown
- 1998-09-04 TR TR2000/00610T patent/TR200000610T2/xx unknown
- 1998-09-04 CO CO98050794A patent/CO4970746A1/es unknown
- 1998-09-04 CA CA002302364A patent/CA2302364A1/en not_active Abandoned
- 1998-09-04 KR KR1020007002326A patent/KR20010023673A/ko not_active Application Discontinuation
- 1998-09-04 BR BR9811751-3A patent/BR9811751A/pt not_active Application Discontinuation
- 1998-09-04 AU AU92233/98A patent/AU731182B2/en not_active Ceased
- 1998-09-04 CN CN98810929A patent/CN1278721A/zh active Pending
- 1998-09-04 PL PL98339133A patent/PL339133A1/xx unknown
- 1998-09-04 ES ES98944775T patent/ES2248916T3/es not_active Expired - Lifetime
-
2000
- 2000-02-29 NZ NZ503125A patent/NZ503125A/en unknown
- 2000-03-03 NO NO20001099A patent/NO315467B1/no not_active IP Right Cessation
- 2000-11-13 HK HK00107224A patent/HK1028730A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2302364A1 (en) | 1999-03-11 |
| AR015426A1 (es) | 2001-05-02 |
| WO1999011253A1 (en) | 1999-03-11 |
| TR200000610T2 (tr) | 2000-09-21 |
| CN1278721A (zh) | 2001-01-03 |
| ZA988101B (en) | 1999-03-05 |
| EP1003497A1 (de) | 2000-05-31 |
| HK1028730A1 (en) | 2001-03-02 |
| KR20010023673A (ko) | 2001-03-26 |
| AU9223398A (en) | 1999-03-22 |
| DE69831413T2 (de) | 2006-06-14 |
| NZ503125A (en) | 2002-05-31 |
| ES2248916T3 (es) | 2006-03-16 |
| IL134854A0 (en) | 2001-05-20 |
| AU731182B2 (en) | 2001-03-22 |
| NO315467B1 (no) | 2003-09-08 |
| CO4970746A1 (es) | 2000-11-07 |
| BR9811751A (pt) | 2001-11-13 |
| JP2001514217A (ja) | 2001-09-11 |
| HUP0003581A3 (en) | 2002-11-28 |
| ATE303370T1 (de) | 2005-09-15 |
| HUP0003581A2 (hu) | 2001-09-28 |
| NO20001099L (no) | 2000-03-03 |
| US6316478B1 (en) | 2001-11-13 |
| NO20001099D0 (no) | 2000-03-03 |
| EP1003497A4 (de) | 2002-11-13 |
| PL339133A1 (en) | 2000-12-04 |
| EP1003497B1 (de) | 2005-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20001100D0 (no) | IL-8 reseptorantagonister | |
| NO986110D0 (no) | IL-8 reseptor-antagonister | |
| NO986109D0 (no) | IL-8 reseptor-antagonister | |
| NO983737L (no) | IL-8 reseptor antagonister | |
| DE69812096T2 (de) | Neuropeptid y rezeptorantagonisten | |
| NO990668L (no) | IL-8 reseptor antagonister | |
| DE69833073D1 (de) | CCR-3-Rezeptor-Antagonisten | |
| DE69734833D1 (de) | Vitronektin rezeptor antagonisten | |
| EP0991406A4 (de) | Il-8 rezeptorantagonisten | |
| DE69921351D1 (de) | 4-aroyl-piperidin-ccr-3 rezeptor antagonisten iii | |
| NO993350D0 (no) | Vitronectin-reseptor-antagonister | |
| EP1000017A4 (de) | Antagonisten des il-8-rezeptors | |
| ID24726A (id) | Antagonis-antagonis reseptor trombin | |
| ID24162A (id) | Antagonis-antagonis reseptor vitronektin | |
| NO20016053D0 (no) | IL-8 reseptor-antagonister | |
| ATE381330T1 (de) | Il-8 rezeptor-antagonisten | |
| NO20016052D0 (no) | IL-8-reseptor-antagonister | |
| ATE303370T1 (de) | Il-8 rezeptor antagonisten | |
| DE69824837D1 (de) | Il-8-rezeptor-antagonisten | |
| DK1180028T3 (da) | IL-8-receptorantagonister | |
| NO20015774L (no) | IL-8 reseptorantagonister | |
| NO20010353L (no) | IL-8 reseptor-antagonist | |
| NO20016065D0 (no) | IL-8-reseptor-antagonister | |
| NO20016102D0 (no) | IL-8 reseptorantagonister |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |